|
|
|
| Webinar: Utilizing a Stepwise Approach for Nitrosamine Risk Mitigation | Mandatory nitrosamine testing has driven stricter standards for drug development. Join Cambrex's Todd Sprouse as he shares a stepwise, product-specific approach to detect, quantify, and control nitrosamine impurities efficiently. Key topics include risk evaluation, formation feasibility, analytical method development, and mitigation through targeted testing of materials. Click here to learn more. |
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | According to Global Data, the total deal value of U.S. licensing of innovator drug candidates from Chinese biopharma companies has surged since 2020. This is an area way upstream of the current tariff focus on manufacturing. But how this R&D trend and those tariffs play out will impact your U.S.-based CDMOs. | |
|
|
A Practical Guide To Defining Priority Data In MES | By BioPhorum | Manufacturing execution systems (MES) play a crucial role in pharma/biotech, but MES platforms face the challenge of identifying the critical data that should be prioritized for supporting effective operations. |
|
|
|
|
|
|
|
Nasal Inhalation Delivery – An Introduction Guide | Article | Upperton Pharma Solutions | Unlock the potential of nasal inhalation for delivering active pharmaceutical ingredients by exploring the benefits of both liquid and dry powder formulations as companies drive innovation in the field. |
|
|
Integrating Early Development With Clinical Supply | Webinar | Catalent | In the era of seamless development, reducing time to the clinic and getting rapid approval is key. An integrated approach can accelerate timelines, avoid communication pitfalls, and improve outcomes. |
|
|
|
|
|
|
| Discover how CDMOs can help you achieve and maintain CMC compliance throughout the drug development lifecycle. Outsourced Pharma Live will explore how to leverage CDMO expertise in process optimization, documentation, and regulatory submissions. Learn practical strategies to align your CMC goals with CDMO capabilities to accelerate development and ensure successful drug launches. Registration is free thanks to the support of Curia. |
|
|
|
|
|
Solid Form Services | Lonza | We have defined work flows to assess and select solid forms in a cost and time efficient manner that meets the needs of each individual program. |
|
|
Pharmaceutical Outsourcing | Adare Pharma Solutions | Discover how Adare's innovative technologies, global reach, and commitment to quality and patient centricity can deliver exceptional solutions for your oral solid dose needs. |
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
Connect With Outsourced Pharma: |
|
|
|